Adverum Biotechnologies Inc (NASDAQ: ADVM) stock enjoyed a major increase of 10.4% on 3/19/25. The shares closed at $5.41. Trading volume in this advance was normal. The stock has risen 21.0% during the last week but has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Adverum Biotechnologies has a current Value Trend Rating of C (Low Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Adverum Biotechnologies has a good Appreciation Score of 79 but a very low Power Rating of 10, resulting in the Low Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment